Effective September 16, 2019.
Goal (Optimum)
0 – 99 Years:
≤ 123 nmol/min/mL
High-Risk
0 – 99 Years:
> 123 nmol/min/mL
Any additional information will be included in a future Technical Update. If you have any questions about these changes, please contact Client Services for assistance.
Effective September 5, 2019.
Interfaced Clients: These updates may require changes to the Test Build.
Effective August 29, 2019.
FTESTO will be made obsolete on August 29, 2019.
This test will be replaced with Testosterone, Total and Free, Serum (TFTEST). Learn more about this test discontinuation.
Any additional information will be included in a future Technical Update. If you have any questions about these changes, please contact Client Services for assistance.
Effective August 19, 2019.
Serine Protease 3, IgG will change to Serine Proteinase 3, IgG.
Effective August 19, 2019.
0 – 3 Years:
Not Established
4 – 10 Years:
1 – 14 µg/d
11 – 17 Years:
1 – 18 µg/d
18 – 99 Years:
1 – 14 µg/d
Effective August 19, 2019.
Jo-1 Antibody, IgG
Negative:
29 AU/mL or less
Equivocal:
30 – 40 AU/mL
Positive:
41 AU/mL or greater
PL-7 (threonyl-tRNA synthetase) Antibody:
Negative
PL-12 (alanyl-tRNA synthetase) Antibody:
Negative
EJ (glycyl-tRNA synthetase) Antibody:
Negative
SRP (Signal Recognition Particle) Ab:
Negative
OJ (isoleucyl-tRNA synthetase) Antibody:
Negative
Mi-2 (nuclear helicase protein) Antibody:
Negative
P155/140 Antibody:
Negative
SAE1 (SUMO activating enzyme) Antibody:
Negative
MDA5 (CADM-140) Antibody:
Negative
NXP-2 (Nuclear matrix protein-2) Antibody:
Negative
TIF-1 gamma (155 kDa) Antibody:
Negative
Effective August 19, 2019.
Therapeutic Range:
5 – 30 µg/mL
Dose-Related Range (values at dosages of 800 – 7200 mg/day):
3 – 30 µg/mL
Effective September 23, 2019.
No fibrosis
FibroTest Score: ≥ 0 and ≤ 0.21
Metavir Score: F0
No fibrosis
FibroTest Score: > 0.21 and ≤ 0.27
Metavir Score: F0 – F1
Minimal fibrosis
FibroTest Score: > 0.27 and ≤ 0.31
Metavir Score: F1
Minimal fibrosis
FibroTest Score: > 0.31 and ≤ 0.48
Metavir Score: F1 – F2
Moderate fibrosis
FibroTest Score: > 0.48 and ≤ 0.58
Metavir Score: F2
Advanced fibrosis
FibroTest Score: > 0.58 and ≤ 0.72
Metavir Score: F3
Advanced fibrosis
FibroTest Score: > 0.72 and ≤ 0.74
Metavir Score: F3 – F4
Severe fibrosis
FibroTest Score: > 0.74 and ≤ 1.00
Metavir Score: F4
No activity
ActiTest Score: ≥ 0 and ≤ 0.17
Metavir Score: A0
No activity
ActiTest Score: > 0.17 and ≤ 0.29
Metavir Score: A0 – A1
Minimal activity
ActiTest Score: > 0.29 and ≤ 0.36
Metavir Score: A1
Minimal activity
ActiTest Score: > 0.36 and ≤ 0.52
Metavir Score: A1 – A2
Significant activity
ActiTest Score: > 0.52 and ≤ 0.60
Metavir Score: A2
Significant activity
ActiTest Score: > 0.60 and ≤ 0.62
Metavir Score: A2 – A3
Severe activity
ActiTest Score: > 0.62 and ≤ 1.00
Metavir Score: A3
Effective August 19, 2019.
Interfaced Clients: These updates may require changes to the Test Build.
Any additional information will be included in a future Technical Update. If you have any questions about these changes, please contact Client Services for assistance.
Effective May 20, 2019.
Volume:
1 mL, 24-hour urine
Minimum Volume:
0.5 mL
Collection Container:
Clean container
Transport Temperature:
Refrigerated
Samples with additives will be rejected.
Effective August 28, 2019.
Interfaced Clients: These updates may require changes to the Test Build.
Thyroid Stimulating Immunoglobulin:
< 0.55 IU/L
Thyroid Stimulating Immunoglobulin, Qualitative:
Negative
Thyroid Stimulating Immunoglobulin:
< 0.55 IU/L
Thyroid Stimulating Immunoglobulin, Qualitative:
Negative
TSH Binding Inhibition (0 – 99 Years):
< 1.0 U/L
Any additional information will be included in a future Technical Update. If you have any questions about these changes, please contact Client Services for assistance.
Effective May 21, 2019.
≤ 0.8 IV:
Negative
No significant level of cysticercosis IgG antibody detected
0.9 – 1.1 IV:
Equivocal
Questionable presence of cysticercosis IgG antibody detected; repeat testing in 10-14 days may be helpful
≥ 1.2 IV:
Positive
IgG antibodies to cysticercosis detected, which may suggest current or past infection
Effective June 3, 2019.
Male:
≥ 115 mg/dL
Female:
≥ 125 mg/dL
Effective June 4, 2019.
≤ 7 days:
< 5.4 mg/dL
8 – 14 days:
< 3.6 mg/dL
≥ 15 days:
< 2.0 mg/dL
Effective July 2, 2019.
Hemoglobin Fetal:
0.0 – 0.9%
Hemoglobin A2 Percent:
2.0 – 3.1%
Effective May 21, 2019.
Due to the lack of availability of the appropriate tubes, this test has been discontinued.
We suggest ordering D-Dimer (DDMER).
Any additional information will be included in a future Technical Update. If you have any questions about these changes, please contact Client Services for assistance.
Effective April 24, 2019.
Effective May 20, 2019.
Volume:
8 inches of umbilical cord (approximately the width of a sheet of paper)
Minimum Volume:
6 inches
Collection Instructions:
Drain and discard any blood. Rinse the exterior of the cord segment with normal saline or water. Pat the cord dry and transport the specimen in a routine urine collection cup or use a Security Kit for Meconium/Umbilical Drug Detection.
Transport Temperature:
Refrigerated
Reference Range:
Gabapentin: Cut-off 10 ng/g
Buprenorphine-G will be removed; all other reference ranges will remain the same.
Volume:
8 inches of umbilical cord (approximately the width of a sheet of paper)
Minimum Volume:
8 inches
Collection Instructions:
Drain and discard any blood. Rinse the exterior of the cord segment with normal saline or water. Pat the cord dry and transport the specimen in a routine urine collection cup or use a Security Kit for Meconium/Umbilical Drug Detection.
Transport Temperature:
Refrigerated
Reference Range:
Gabapentin: Cut-off 10 ng/g
Buprenorphine-G will be removed; all other reference ranges will remain the same.
Volume:
8 inches of umbilical cord (approximately the width of a sheet of paper)
Minimum Volume:
6 inches
Collection Instructions:
Drain and discard any blood. Rinse the exterior of the cord segment with normal saline or water. Pat the cord dry and transport the specimen in a routine urine collection cup or use a Security Kit for Meconium/Umbilical Drug Detection.
Transport Temperature:
Refrigerated
These updates may require changes to the Test Build for interfaced clients.
Effective May 20, 2019.
Effective May 20, 2019.
5-Fluorouracil Toxicity, Chemo Response, 5 Mut (5FLUO)
We suggest ordering Dihydropyrimidine Dehydrogenase (DPYD), 3 Variants (5FUDPD).
Cytochrome P450 2D6 (CYP2D6) Geno (2D6GEN)
We suggest ordering the new test, CYP2D6 (Cytochrome P450 2D6) (2D6GTP).
Cyto P450 2C19 – 9 Variants (2C19PL)
We suggest ordering the new test, CYP2C19 (Cytochrome P450 2C19) (2C19CY).
Warfarin Sensitivity Genotyping (WARSEN)
We suggest ordering new test Warfarin Sensitivity (CYP2C8, CYP2C9, CYP4F2, VKORC1) Genotyping (WRFSEN).
Fats, Urine (UFAT)
Effective May 29, 2019.
Volume:
1 mL, serum
Minimum Volume:
0.25 mL
Collection Container:
Red (Serum) No Additive Tube
Collection Instructions:
Allow sample to clot, then separate serum from cells as soon as possible. Centrifuge, then remove serum and freeze at minus 20°C or colder (up to 7 days post-draw). Minus 70 °C or colder is preferred and is acceptable up to 30 days post-draw.
Transport Temperature:
Frozen
Effective June 24, 2019.
These updates may require changes to the Test Build for interfaced clients.
HIV-1 Integrase Genotype (HIVIGT)
Any additional information will be included in a future Technical Update. If you have any questions about these changes, please contact Client Services for assistance.
Effective December 31, 2018.
Volume:
0.8 mL, serum
Minimum Volume:
0.4 mL, serum
Collection Container:
Gold BD Hemogard™ Serum Separation Tube (SST)™
Alternate Container:
Red BD Hemogard™ Serum Tube
Specimen Instructions:
Centrifuge the specimen, then aliquot serum into a standard, non-sterile aliquot tube.
Transport Temperature:
Refrigerated
Effective January 11, 2019.
Volume:
0.5 mL, serum
Minimum Volume:
0.1 mL, serum
Collection Container:
Gold BD Hemogard™ Serum Separation Tube (SST)™
Transport Temperature:
Frozen
Ambient:
8 hours
Refrigerated:
48 hours
Frozen:
14 days
Methodology:
Enzyme-Linked Immunosorbent Assay (ELISA)
Reference Range:
< 7.5 U/mL
Effective January 15, 2019.
Ambient:
48 hours
Refrigerated:
Unacceptable
Frozen:
Unacceptable
Any additional information will be included in a future Technical Update. If you have any questions about these changes, please contact Client Services for assistance.
Effective December 7, 2017.
Ambient:
24 hours
Refrigerated:
24 hours
Frozen:
2 months – freeze once and protect from light
232 – 1245 pg/mL
Changes effective as of November 5, 2018.
Separate specimens must be submitted when multiple tests are ordered.
Volume:
1 mL, serum
Minimum Volume:
0.25 mL
Collection Container:
Red BD Hemogard™ Serum Tube (No Additive)
Collection Instructions:
Allow blood to clot for 20 – 60 minutes at room temperature (or 37 °C), then centrifuge. Aliquot serum into a standard aliquot tube, then freeze the specimen immediately on dry ice or at -70 °C.
Do not draw gel separator tubes.
Transport Temperature:
Critical Frozen – send the frozen specimen via Priority Overnight in a well-insulated container on dry ice.
Thawed specimens or specimens stored at or above -20°C will not be accepted.
Reference Range
• 116,373 – 264,072 units/mL
Separate specimens must be submitted when multiple tests are ordered.
Volume:
1 mL, plasma
Minimum volume:
0.5 mL
Collection Container:
Lavender BD Hemogard™ K2EDTA Tube
Collection Instructions:
Mix well. Centrifuge the specimen at room temperature within 30 minutes of collection, then transfer the plasma to a standard aliquot tube. Immediately freeze the specimen on dry ice or at -70°C.
Transport Temperature:
Critical Frozen – send the frozen specimen via Priority Overnight in a well-insulated container on dry ice.
Thawed specimens or specimens stored at or above -20°C will not be accepted.
Reference Range
• 0 – 780 ng/mL
Separate specimens must be submitted when multiple tests are ordered.
Volume:
1 mL, plasma
Minimum volume:
0.5 mL
Collection Container:
Lavender BD Hemogard™ K2EDTA Tube
Collection Instructions:
Mix well. Centrifuge at room temperature within 30 minutes of collection, then transfer plasma to a standard aliquot tube and freeze immediately. Plasma may be frozen at -20°C then transferred to dry ice for shipment within 6 hours or immediately frozen on dry ice/at -70°C or below.
Transport Temperature:
Critical Frozen – send the frozen specimen via Priority Overnight in a well-insulated container on dry ice.
Thawed specimens or specimens stored at room temperature prior to shipment are unacceptable.
Reference Range
• 0 – 2,830 ng/mL
Any additional information will be included in a future Technical Update. If you have any questions about these changes, please contact Client Services for assistance.
Effective November 12, 2018.
Previously Aspergillus fumigatus Antibody, IgG by ELISA
Volume:
0.5 mL, serum
Minimum Volume:
0.2 mL
Specimen Container:
Gold BD Hemogard™ Serum Separation Tubes (SST)™
Volume:
1 mL, serum
Specimen Container:
Red BD Hemogard™ Serum Tube (No Additive)
Do not draw Gold Serum Separation Tube (SST) tubes.
Volume:
2 mL, serum
Minimum Volume:
0.7 mL
Specimen Container:
Red BD Hemogard™ Serum Tube (No Additive)
Volume (Alternative):
2 mL, plasma
Minimum Volume:
0.7 mL
Alternative Specimen Container:
Lavender BD Hemogard™ K2EDTA Tube
Effective November 26, 2018.
Volume:
0.5 mL, serum
Specimen Container:
Red BD Hemogard™ Serum Tube (No Additive)
Transport Temperature:
Ambient (room temperature)
Effective November 27, 2018.
Volume:
1 mL, plasma
Specimen Container:
Green Sodium Heparin or Lithium Heparin Tube
Volume (Alternative):
1 mL, serum
Alternative Specimen Container:
Red BD Hemogard™ Serum Tube (No Additive)
Any additional information will be included in a future Technical Update. If you have any questions about these changes, please contact Client Services for assistance.
